Sitagliptin phosphate and Oxycodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sitagliptin phosphate (sitagliptin phosphate) and Oxycodone (oxycodone hydrochloride). Common drug interactions include calciphylaxis among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Sitagliptin phosphate and Oxycodone. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Sitagliptin phosphate?

Sitagliptin phosphate has active ingredients of sitagliptin phosphate. eHealthMe is studying from 3,787 Sitagliptin phosphate users. Check the latest studies of Sitagliptin phosphate.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.

On Jul, 21, 2026

37 people who take Sitagliptin phosphate and Oxycodone together, and have interactions are studied.

Sitagliptin phosphate and Oxycodone drug interactions.

What are the common drug interactions of Sitagliptin Phosphate and Oxycodone, by gender? *:

female:

Calciphylaxis (is a syndrome with vascular calcium accumulation)
Diabetic ulcer
International normalised ratio increased
Rectal haemorrhage (bleeding from anus)
Asthenia (weakness)
Blood creatinine increased
Chronic kidney disease
Confusional state
Dizziness
Fatigue (feeling of tiredness)

male:

Diarrhoea
Malignant neoplasm progression (cancer tumour came back)
Platelet count decreased
Subileus
Interstitial lung disease
Amylase increased
Anxiety
Blood amylase increased
Blood creatine increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the common drug interactions of Sitagliptin Phosphate and Oxycodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Drug ineffective
Hidradenitis (chronic disease of a type of sweat gland)
Dyskinesia (abnormality or impairment of voluntary movement)
Feeling jittery
Tremor (trembling or shaking movements in one or more parts of your body)
Vision blurred

50-59:

Renal failure (kidney dysfunction)
Oedema peripheral (superficial swelling)
Anxiety
Chronic kidney disease
Dehydration (dryness resulting from the removal of water)
Intestinal obstruction
Lipase increased
Subileus
Amylase increased
Anhedonia (inability to experience pleasure from activities usually found enjoyable)

60+:

Diarrhoea
Malignant neoplasm progression (cancer tumour came back)
Asthenia (weakness)
Confusional state
Dizziness
Fatigue (feeling of tiredness)
Platelet count decreased
Interstitial lung disease
Biliary cirrhosis (biliary cirrhosis occurs due to obstruction to the flow of bile through bile ducts either within the liver or outside the liver)
Blood creatine increased

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 18.92%
Diabetes: 7 people, 18.92%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 13.51%
Multiple Myeloma (cancer of the plasma cells): 5 people, 13.51%
Oedema (fluid collection in tissue): 3 people, 8.11%
Insomnia (sleeplessness): 3 people, 8.11%
Sleep Disorder: 3 people, 8.11%
Diarrhea: 3 people, 8.11%
Bronchial Carcinoma (lung cancer): 2 people, 5.41%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Sitagliptin phosphate and Oxycodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously